Mobile

Efficacy and safety of the S 05985 combination compared with each individual component: randomised, double-blind, placebo-controlled study over eight weeks in hypertensive patients

Mise à jour : Il y a 4 ans
Référence : ISRCTN14235381

Femme et Homme

Extrait

Not provided at time of registration and not expected to be available in the future

Critère d'inclusion

  • Essential arterial hypertension

Liens